PhaseBio Pharmaceuticals' Unattributed VC Round

PhaseBio Pharmaceuticals raised a round of funding on January 23, 2002. Investors include Catalysta Ventures.

PhaseBio Pharmaceuticals (PHAS) is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's …

Articles about PhaseBio Pharmaceuticals' Unattributed VC Round: